Someone I know asked FINRA about the daily short volume and

New Post Public Reply Private Reply Replies (6) Message Board
sox0407 AlanC #38443
1,033
Someone I know asked FINRA about the daily short volume and here's the answer. You and others are welcome to confirm it. If you want to know whom to contact, just let me know.

Question:
Quote:
I'm seeing the following posted daily on many stocks. Please clarify what this data is actually saying since I don't believe that 32% of the volume was actual short sales. This data appears to be used to scare investors into believing specific stocks have serious shorting issues.

FINRA short sales of IPIX
20171018|IPIX|52063|0|161293|O
32% of today's volume was short sales!
Go IPIX!!!
regsho.finra.org/FORFshvol20171018.txt

Thank you for your help.


Answer:
Quote:
Dear Ms. xxxxxxx,

Thank you for contacting FINRA’s Office of the Ombudsman. Regarding your question, it would be incorrect to assume that short sales comprise 32% of the total volume on that trading day for IPIX. FINRA publishes the daily short sale volume pursuant to an SEC mandate; however, there are various trading anomalies that result in the reported short sale volume often being exaggerated. Thus, the true total short sales volume may be significantly lower than the volume that is reported. Third parties sometimes ignore this and try to claim the ratio is valid to further their own objectives.

It is a bit complex to explain via email. If you would like to discuss it, please call me and I can explain further.

By way of background, FINRA’s Office of the Ombudsman provides a neutral and confidential forum for member firms and their employees, public investors, and any other business or individual who interacts with FINRA to voice their concerns about operations, enforcement, or other FINRA activities or staff. Individuals who are unsure of the proper channel for addressing a concern or feel that the issue cannot be resolved through other channels may also contact the Ombudsman’s Office. Additional information can be found online at: www.finra.org/about/office-ombudsman.

Upon conclusion of your contact with FINRA's Office of the Ombudsman, if you have feedback on your interaction, please take our brief, anonymous survey at https://www.surveymonkey.com/s/FINRAOmbudsman. All information you provide is strictly confidential and will not be attributed to you in any way.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Dont-give-up.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 3

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 3

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 3

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading

Top 5 Most Recently Viewed Articles

How a $100 Investment in Casey's General Stores Grew

Updated Category News Views 183

Understanding the Growth of Casey's General Stores Casey's General Stores (NASDAQ: CASY) has notably outperformed the market over the last decade. Investors have been delighted with an annualized return of approximately 16.93%, surpassing the market by 4.4%. A remarkable market capitalization of $19.79 billion reflects the company's robust position within the retail...

Continue Reading
THEON's 2024 Results Show Strong Growth and Future Potential

Updated Category News Views 394

THEON's Strong FY 2024 Performance Surpasses Expectations THEON International Plc, listed on Euronext Amsterdam as (THEON), has released its preliminary financial results for FY 2024, illustrating a remarkable performance throughout the year. With a solid strategy in place, the company not only met but exceeded its revenue guidance, showcasing its robust business model...

Continue Reading
Important Class Action Information for Ultra Clean Investors

Updated Category News Views 241

Essential Class Action Information for Investors In recent developments, Robbins LLP emphasizes the importance for stockholders of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) who may have faced significant financial losses due to misleading company statements. The class action suits have been filed to protect investors who acquired securities within a specific time frame....

Continue Reading
Sable Resources Secures Additional $5 Million for Exploration

Updated Category News Views 206

Sable Resources Secures Additional $5 Million for Exploration VANCOUVER, British Columbia — Sable Resources Ltd. (TSXV:SAE | OTCQB:SBLRF) has officially announced a significant financial development. The company has received a $5 million payment from OR Royalties Inc. This payment is tied to the royalty agreement regarding TDG Gold Corp. which Sable sold to OR. This...

Continue Reading